Arcutis Biotherapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Arcutis Biotherapeutics Inc 's inventory turnover ratio sequentially decreased to 1.24 in the third quarter 2026, otherwise the ratio remained above the average, as ARQT's markets remain strong.Arcutis Biotherapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 294 days, from 270 days, in the Jun 30 2026 quarter.

Within Healthcare sector 279 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1445 in the second quarter 2026, to 1717.

ARQT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Arcutis Biotherapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ARQT Inventory Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Inventory Growth	103.71 %	138.17 %	125.06 %	55.82 %	59.96 %
Y / Y Cost of Sales Growth	43.47 %	46.01 %	10.8 %	69.27 %	57.82 %
Inventory Turnover Ratio (TTM)	1.24	1.35	1.52	1.88	1.83
ARQT's Total Ranking	# 1717	# 1445	# 1062	# 725	#
Average inventory processing period	294	269	239	194	200
Seq. Inventory Growth	17.46 %	3.98 %	65.2 %	0.96 %	37.34 %
Seq. Cost of Sales Growth	13.9 %	11.8 %	-16.29 %	34.58 %	15.92 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 77
Healthcare Sector	# 280
Overall Market	# 1717

Inventory Turnover Ratio Statistics
High	Average	Low
1.88	1.15	0.3
(Dec 31 2025)		(Jun 30 2023)

ARQT Company Profile >> Back to ARQT Efficiency Comparisons >> Compare ARQT Inventory Turnover Ratio to its Competitors

Financial Statements
Arcutis Biotherapeutics Inc 's Inventories	$ 46 Millions	Visit ARQT's Balance sheet
Arcutis Biotherapeutics Inc 's Cost of Revenues TTM	$ 45 Millions	Visit ARQT's Income Statement
What are ARQT's Sales?		Visit ARQT's Sales by Segment

Other Inventory Turnover Ratios
Arcutis Biotherapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ARQT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ARQT's Competitors
Inventory Turnover Ratio for ARQT's Suppliers
Inventory Turnover Ratio for ARQT's Customers

You may also want to know
ARQT's Sales Growth Rates	ARQT's Pe Price to earnings ratio	ARQT's Receivables Turnover Ratio	ARQT's Stock Quote
ARQT's Net Income Growth Rates	ARQT's Ps Price to Sales ratio	ARQT's Sales per Employee	ARQT's Asset Turnover Ratio
ARQT's Net Margin	ARQT's Pb Price to Book ratio	ARQT's Financial Strength Ratios	ARQT's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2026	Inventories at quarter ending Sep 30 2026
Biomerica Inc	2.65	$ 4.297 Millions	$ 2 Millions
Dexcom Inc	2.65	$ 1,867.500 Millions	$ 705 Millions
Angiodynamics Inc	2.50	$ 142.709 Millions	$ 57 Millions
Pro dex Inc	2.45	$ 53.753 Millions	$ 22 Millions
Illumina Inc	2.36	$ 1,458.000 Millions	$ 618 Millions
Mirum Pharmaceuticals Inc	2.35	$ 59.684 Millions	$ 25 Millions
Aquestive Therapeutics Inc	2.34	$ 16.928 Millions	$ 7 Millions
Resmed Inc	2.33	$ 2,214.675 Millions	$ 952 Millions
Beta Bionics Inc	2.31	$ 53.285 Millions	$ 23 Millions
Merit Medical Systems Inc	2.25	$ 817.001 Millions	$ 363 Millions
Bioventus Inc	2.24	$ 183.856 Millions	$ 82 Millions
Johnson and Johnson	2.17	$ 32,222.000 Millions	$ 14,824 Millions
Standard Biotools Inc	2.16	$ 39.539 Millions	$ 18 Millions
Glaukos Corp	2.13	$ 131.180 Millions	$ 62 Millions
Organon and Co	2.08	$ 2,859.000 Millions	$ 1,371 Millions
Repligen Corp	2.07	$ 372.472 Millions	$ 180 Millions
Boston Scientific Corporation	2.06	$ 6,502.000 Millions	$ 3,153 Millions
Bausch and Lomb Corp	2.01	$ 1,986.000 Millions	$ 990 Millions
Clearpoint Neuro Inc	1.98	$ 17.564 Millions	$ 9 Millions
Intuitive Surgical Inc	1.91	$ 3,799.300 Millions	$ 1,986 Millions
Indivior Pharmaceuticals Inc	1.88	$ 208.000 Millions	$ 111 Millions
Tenet Healthcare Corp	1.88	$ 642.000 Millions	$ 342 Millions
Iradimed Corporation	1.78	$ 21.878 Millions	$ 12 Millions
Ceribell Inc	1.74	$ 12.160 Millions	$ 7 Millions
Axsome Therapeutics Inc	1.67	$ 58.422 Millions	$ 35 Millions
Insmed Inc	1.66	$ 237.067 Millions	$ 143 Millions
Stryker Corp	1.66	$ 9,116.000 Millions	$ 5,499 Millions
Pfizer Inc	1.64	$ 16,940.000 Millions	$ 10,322 Millions
Integra Lifesciences Holdings Corp	1.62	$ 789.329 Millions	$ 486 Millions
Conmed Corporation	1.61	$ 580.951 Millions	$ 361 Millions

Date modified: 2026-11-06T13:03:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.